CytoMed Therapeutics Ltd (GDTC) Stock Price & News

All values in SGD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	205.08K	205.08K	189.44K	189.44K
Cost of goods sold	31.99K	31.99K	23.66K	23.66K
Cost of revenue	31.99K	31.99K	23.66K	23.66K
Research and development expenses	527.51K	527.51K	547.78K	547.78K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	294.91K	294.91K	194.40K	194.40K
Operating expense	1.27M	1.27M	1.07M	1.07M
Total operating expenses	1.30M	1.30M	1.09M	1.09M
Operating income	-1.10M	-1.10M	-901.91K	-901.91K
Other non operating income	31.60K	31.60K	2.18K	2.18K
EBT including unusual items	-875.25K	-875.25K	-897.07K	-897.07K
EBT excluding unusual items	-1.02M	-1.02M	-896.95K	-896.95K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	370.51K	370.51K	268.90K	268.90K
Net income	-868.35K	-868.35K	-885.23K	-885.23K
Net profit margin	-423.42%	-423.42%	-467.29%	-467.29%
Earnings per share	-	-	-	-
Interest and investment income	19.05K	19.05K	4.78K	4.78K
Interest expense	-5.30K	-5.30K	-5.07K	-5.07K
Net interest expenses	13.75K	13.75K	-295.00	-295.00
Depreciation and amortization charges	58.31K	58.31K	63.91K	63.91K
EBITDA	-995.61K	-995.61K	-783.53K	-783.53K
Gain or loss from assets sale	-122.00	-122.00	125.00	125.00

Finance